The University of Chicago Header Logo

Connection

John Fung to Histocompatibility Testing

This is a "connection" page, showing publications John Fung has written about Histocompatibility Testing.
Connection Strength

0.696
  1. High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms. Am J Transplant. 2015 Oct; 15(10):2780-1.
    View in: PubMed
    Score: 0.125
  2. Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant. 2015 Apr; 15(4):923-30.
    View in: PubMed
    Score: 0.122
  3. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.094
  4. The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
    View in: PubMed
    Score: 0.045
  5. Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc. 1999 Aug; 31(5):2028-31.
    View in: PubMed
    Score: 0.041
  6. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 1997 Oct 15; 64(7):983-91.
    View in: PubMed
    Score: 0.037
  7. Explanation for loss of the HLA matching effect. Transplant Proc. 1995 Feb; 27(1):57-60.
    View in: PubMed
    Score: 0.030
  8. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
    View in: PubMed
    Score: 0.028
  9. Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc. 1993 Jun; 25(3):2381-5.
    View in: PubMed
    Score: 0.027
  10. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
    View in: PubMed
    Score: 0.026
  11. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis. 1992 Feb; 12(1):51-9.
    View in: PubMed
    Score: 0.025
  12. The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc. 1991 Dec; 23(6):3021-2.
    View in: PubMed
    Score: 0.024
  13. The antibody crossmatch in liver transplantation. Surgery. 1986 Oct; 100(4):705-15.
    View in: PubMed
    Score: 0.017
  14. Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol. 2003 Aug; 64(8):787-95.
    View in: PubMed
    Score: 0.014
  15. The long-term efficacy of multivisceral transplantation. Transplant Proc. 2000 Sep; 32(6):1219-20.
    View in: PubMed
    Score: 0.011
  16. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
    View in: PubMed
    Score: 0.009
  17. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc. 1996 Oct; 28(5):2959-65.
    View in: PubMed
    Score: 0.009
  18. Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):888-90.
    View in: PubMed
    Score: 0.007
  19. HLA histocompatibility and liver transplant survival. Transplant Proc. 1987 Aug; 19(4 Suppl 3):63-5.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.